ARTICLE | Company News
Sol, Agenus deal
September 7, 2015 7:00 AM UTC
Sol’s Diatheva s.r.l. subsidiary granted Agenus exclusive, worldwide rights to develop and commercialize undisclosed antibodies against carcinoembryonic antigen (CEA)-related cell adhesion molecule 1...